Over the past ten years, the nutraceutical sector has experienced significant growth: approximately 8% annually, more than €5 billion in sales in 2025, and a global market that could reach $240 billion by 2027 (source: Integratori & Salute).
Italy is currently the largest market in Europe.

This expansion has led to the emergence of numerous new brands and formulations. However, the competitive landscape is rapidly evolving. More and more companies are realizing that having a good product is no longer enough.
The real differentiating factor is becoming scientific credibility.

The “Pharma-fication” of Nutraceuticals

In recent years, the nutraceutical industry has been undergoing a progressive “pharma-fication.”

Consumers are more informed, physicians are more selective, and distribution channels are more demanding. In this scenario, generic claims are gradually losing effectiveness, while demand for solid scientific evidence continues to grow.

For companies, the required shift is primarily strategic.

It means moving from a model where businesses sell products and communicate generic benefits — often competing mainly on price — to a model where companies offer validated solutions, supported by clinical data and increasingly developed in collaboration with healthcare professionals and medical-scientific institutions.

In other words, companies must move away from a consumer goods mindset and closer to the healthcare model.

Companies investing in pharma-grade products supported by clinical evidence are already seeing a very concrete outcome: the ability to apply premium pricing between 25% and 40% higher than traditional competitors.

The so-called “Nutraceutical Pivot” is not simply a marketing or communication initiative. It is a transformation that affects the entire business model.

It requires:

• investments in research and clinical validation
• a redefinition of the value proposition
• a commercial model more oriented toward the medical and specialist channel
• more structured governance in the management of scientific data and claims

In our experience at TrustPartners, companies that successfully manage this transition are those capable of integrating scientific expertise, strategic positioning, and international commercial development.

One often underestimated aspect, for example, is the ability to structure Real-World Evidence (RWE) data collection programs, which not only strengthen product claims but also generate valuable data for engaging with physicians, clinics, and specialized distributors.

The real issue is not only the product formulation, but the long-term vision of the company.

Remaining in the generic wellness segment or evolving toward clinically validated solutions has now become a strategic positioning decision.

Companies that are embracing this path are preparing to compete in a far more mature market, where differentiation will depend not only on the product itself, but on scientific credibility and the ability to demonstrate tangible results.

Those who begin this journey today have the opportunity to build a significant competitive advantage for the next decade.

From Strategy to Implementation

Addressing the Nutraceutical Pivot requires expertise that ranges from market strategy to the operational management of product development.

In this context, many companies face a concrete challenge: transforming a strategic vision into a product portfolio that is truly market-ready.

At TrustPartners, we support nutraceutical companies throughout this process, offering an end-to-end approach that accompanies clients from the initial analysis phase all the way to commercial launch.

Our working model integrates:

• strategic analysis of market trends and therapeutic opportunities
• definition and development of the product portfolio
• selection of active ingredients and the most effective formulations
• management of regulatory notifications and compliance
• development of graphic design and packaging
• support in defining scientific and commercial positioning

Thanks to proprietary product analysis and development tools, combined with hands-on industry expertise, we are able to offer companies a turnkey service, reducing development time and operational complexity.

For many companies in the sector, the real competitive advantage does not come only from the idea of a new product, but from the ability to bring it to market quickly, compliantly, and with strong strategic positioning.

Contact us for a discussion.